-
公开(公告)号：US20240252441A1
公开(公告)日：2024-08-01
申请号：US18425556
申请日：2024-01-29
Applicant: CRITITECH, INC.
Inventor： Gere S. DIZEREGA , Michael BALTEZOR , Sam CAMPBELL , Charles J. DECEDUE , Matthew MCCLOREY , Holly MAULHARDT
IPC: A61K9/16 , A61K9/00 , A61K31/337 , A61K39/00 , C07K16/28
CPC classification number: A61K9/1652 , A61K31/337 , C07K16/2818 , A61K9/0014 , A61K9/0019 , A61K9/0053 , A61K2039/54
Abstract: Disclosed are combination therapy methods useful for the therapeutic treatment of cancer by combining local administration of compositions containing antineoplastic particles, such as taxane particles, with systemic administration of compositions containing immunotherapeutic agents. Local administration methods include topical application, pulmonary administration, intratumoral injection, intraperitoneal injection, and intracystic injection.
-
公开(公告)号：US20190209514A1
公开(公告)日：2019-07-11
申请号：US16239527
申请日：2019-01-04
Applicant: CRITITECH, INC.
Inventor： Gere S. DIZEREGA , Michael BALTEZOR , Charles J. DECEDUE , Sam CAMPBELL , Matthew MCCLOREY
CPC classification number: A61K31/337 , A61K9/0019 , A61K9/0034 , A61K9/08 , A61K9/10 , A61K9/14 , A61K9/16 , A61K47/26 , A61P35/00
Abstract: Disclosed herein are methods for treating and inhibiting the recurrence of bladder cancer by local administration of compositions comprising taxane particles such as docetaxel particles. Administration methods include intratumoral injection, direct injection into surgical tumor resection sites, and intravesical instillation.
-
Patent Agency Ranking
公开(公告)号：US20210214683A1
公开(公告)日：2021-07-15
申请号：US17057945
申请日：2019-04-12
Applicant: CRITITECH, INC.
Inventor： Gere S. DIZEREGA , Holly MAULHARDT , Michael BALTEZOR , Sam CAMPBELL , Charles J. DECEDUE , William JOHNSTON , Matthew MCCLOREY , James VERCO
IPC: C12N5/0783 , A61K39/00 , A61P35/00 , A61K31/337
Abstract: Disclosed are methods for the isolation of tumor-specific immune cells from subjects that have a malignant tumor and have received local administration of a composition comprising taxane particles to the malignant tumor, and use of such isolated immune cells in compositions for adoptive cell therapy and cancer vaccines.
-
公开(公告)号：US20190209515A1
公开(公告)日：2019-07-11
申请号：US16239529
申请日：2019-01-04
Applicant: CRITITECH, INC.
Inventor： Gere S. DIZEREGA , Michael BALTEZOR , Charles J. DECEDUE , Sam CAMPBELL , Matthew MCCLOREY
CPC classification number: A61K31/337 , A61K9/0019 , A61K9/0034 , A61K9/08 , A61K9/10 , A61K9/14 , A61K9/16 , A61K47/26 , A61P35/00
Abstract: Disclosed herein are methods for treating and inhibiting the recurrence of bladder cancer by local administration of compositions comprising taxane particles such as docetaxel particles. Administration methods include intratumoral injection, direct injection into surgical tumor resection sites, and intravesical instillation.
-
公开(公告)号：US20230263731A1
公开(公告)日：2023-08-24
申请号：US18154419
申请日：2023-01-13
Applicant: CRITITECH, INC.
Inventor： Gere S. DIZEREGA , Michael BALTEZOR , Sam CAMPBELL , Charles J. DECEDUE , Matthew MCCLOREY
IPC: A61K9/16 , A61K31/337 , C07K16/28
CPC classification number: A61K9/1652 , A61K31/337 , C07K16/2818 , A61K9/0014
Abstract: Disclosed are combination therapy methods useful for the therapeutic treatment of cancer by combining local administration of compositions containing antineoplastic particles, such as taxane particles, with systemic administration of compositions containing immunotherapeutic agents. Local administration methods include topical application, pulmonary administration, intratumoral injection, intraperitoneal injection, arid intracystic injection.
-
公开(公告)号：US20220096423A1
公开(公告)日：2022-03-31
申请号：US17492231
申请日：2021-10-01
Applicant: CRITITECH, INC.
Inventor： Gere S. DIZEREGA , Michael BALTEZOR , Charles DECEDUE , Sam CAMPBELL , Matthew MCCLOREY
Abstract: Disclosed herein are methods for treating and inhibiting the recurrence of bladder cancer by local administration of compositions comprising taxane particles such as docetaxel particles. Administration methods include intratumoral injection, direct injection into surgical tumor resection sites, and intravesical instillation.
-
公开(公告)号：US20200261367A1
公开(公告)日：2020-08-20
申请号：US16834155
申请日：2020-03-30
Applicant: CRITITECH, INC.
Inventor： Gere S. DIZEREGA , Michael BALTEZOR , Sam CAMPBELL , Charles J. DECEDUE , Matthew MCCLOREY
IPC: A61K9/16 , A61K31/337 , C07K16/28
Abstract: Disclosed are combination therapy methods useful for the therapeutic treatment of cancer by combining local administration of compositions containing antineoplastic particles, such as taxane particles, with systemic administration of compositions containing immunotherapeutic agents. Local administration methods include topical application, pulmonary administration, intratumoral injection, intraperitoneal injection, and intracystic injection.
-
-
-
-
-
-
Search Results
7
records
(took 0.012 seconds)
